Fairtility

Fairtility is a healthcare technology company based in Tel Aviv, Israel, focused on enhancing in vitro fertilization (IVF) outcomes through transparent artificial intelligence (AI). The company has developed CHLOE (Cultivating Human Life through Optimal Embryos), a unique AI-based decision support tool that provides clinicians with complete visibility into the data used to assess embryo viability and optimize IVF treatments. The flagship product, CHLOE EQ, is an AI-powered embryo grading platform that objectively evaluates embryo quality. This tool enables clinicians to make informed decisions by clarifying the factors that influence embryo viability. Fairtility aims to cover the entire IVF journey, from assessing infertility causes to optimizing embryo transfer. The company also emphasizes streamlined workflows, secure integration with clinical systems, and comprehensive digital tools to support fertility clinics and reproductive health professionals globally. With a strong leadership team and significant funding, Fairtility is dedicated to improving IVF success rates and reducing the emotional and financial burdens on prospective parents.

• Employees 38
• Founded 2020
• Total Funding $15000000